StockData
Faeth Therapeutics, Inc. logo

Faeth Therapeutics, Inc. (FTH) stock

FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$9.04−0.24 (-2.59%)

Close on Nov 17, 2026Market cap $233.60MP/E –Yield –

Faeth Therapeutics r&d expenses

Research and development expenses are spending on new products and technology.

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2021Mar 31, 2021$3.37M–
Q1 FY2020Mar 31, 2020$2.20M–

More Faeth Therapeutics figures

See a number that looks wrong?